Immunotherapy Safe for Cancer Patients with COVID-19: Study
The treatments activate a person's immune system against cancer.
Researchers have been wary, because many COVID-19 complications result from an overactive immune response that leads to increased production of proteins called cytokines that can cause issues such as respiratory failure.
"In patients with both COVID-19 and cancer, our team thought that immunotherapy might increase the immune system response, which could already be overactive because of the COVID-19 infection," researcher Layne Weatherford said in a University of Cincinnati news release. He is a postdoctoral fellow at the university.
For this ongoing study, the researchers are using blood samples from cancer patients with COVID-19. They are looking at how the therapy affects the immune cells of COVID-19 patients, as well as patients with both COVID-19 and cancer.
Preliminary data show that a diabetes drug, metformin, can reduce production of cytokine proteins in COVID-19 patients.
More research is needed, but the researchers said it may be possible to treat COVID-19 complications with metformin or a similar drug.
Weatherford noted that patients with cancer are more susceptible to COVID-19 as well as severe complications from it.
The findings were to be presented Monday at a virtual meeting of the American Association for Cancer Research. Studies presented at meetings are typically considered preliminary until published in a peer-reviewed journal.
© 2020 HealthDay. All rights reserved.
Posted: July 2020
Further Support and Information on COVID-19
Read this next
WEDNESDAY, Sept. 23, 2020 -- If you're unfortunate enough to be admitted to the hospital with COVID-19, a common blood marker may predict how severe your illness might become, new...
WEDNESDAY, Sept. 23, 2020 -- Many heart attack survivors worry that resuming sex too soon afterwards might trigger another attack. But new research suggests the opposite may be...
WEDNESDAY, Sept. 23, 2020 (Healthday News) -- The U.S. coronavirus death toll reached the tragic milestone of 200,000 on Tuesday, with at least 22 states now reporting a rise in...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.